Research Progress on the osteogenic differentiation of ADSCs induced by epimedium in the prevention and treatment of osteoporosis
Osteoporosis (OP) is a chronic, systemic bone disease. With the arrival of the aging society, the research on the prevention and treatment of this disease is increasing. Finding effective drugs to induce osteogenesis and differentiation of adipose-derived mesenchymal stem cells (ADSCs) is currently...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of New Medicine
2023-10-01
|
| Series: | Yixue xinzhi zazhi |
| Subjects: | |
| Online Access: | https://yxxz.whuznhmedj.com/futureApi/storage/attach/2310/XLe2PMc38ZMiLCy3rWw9RFGGg1RSJ2ngw1LbtmAR.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849219935147917312 |
|---|---|
| author | Hai-Quan LIU Mei-Jian-Zong WU Zu-Yu MENG |
| author_facet | Hai-Quan LIU Mei-Jian-Zong WU Zu-Yu MENG |
| author_sort | Hai-Quan LIU |
| collection | DOAJ |
| description | Osteoporosis (OP) is a chronic, systemic bone disease. With the arrival of the aging society, the research on the prevention and treatment of this disease is increasing. Finding effective drugs to induce osteogenesis and differentiation of adipose-derived mesenchymal stem cells (ADSCs) is currently a more focused strategy for prevention and treatment of OP. Peroxisome proliferator-activated receptor gamma (PPARγ) is the key protein of adipocyte differentiation. Studies have confirmed that the intervention of epimedium on bone marrow mesenchymal stem cells (BMSCs) can inhibit the expression of PPARγ, thus inhibits adipogenic differentiation of BMSCs and promotes their osteogenic differentiation. Hippo signal pathway controls the activity of YAP/TAZ transcriptional coactivator through kinase cascade and inhibiting PPARγ, which can inhibit ADSCs from differentiating into adipocytes. Ajuba is an important regulator of adipogenic differentiation of cells and a new PPARγ interacting proteins which can limit the activity of Hippo signaling pathway during cell proliferation. Epimedium has unique advantages in the prevention and treatment of OP. Previous studies found that epimedium can promote the osteogenic differentiation of ADSCs and inhibit their lipogenic differentiation. PPARγ, Hippo pathway and Ajuba are closely related in the pathogenesis of OP. According to previous research, this paper is purposed to review the mechanism of epimedium in ADSCs for the prevention and treatment of OP, and to provide a reference for the development of new clinical drugs. |
| format | Article |
| id | doaj-art-3ea50d8cd8fd436aac10e2aa5df0c14f |
| institution | Kabale University |
| issn | 1004-5511 |
| language | zho |
| publishDate | 2023-10-01 |
| publisher | Editorial Office of New Medicine |
| record_format | Article |
| series | Yixue xinzhi zazhi |
| spelling | doaj-art-3ea50d8cd8fd436aac10e2aa5df0c14f2024-12-25T10:11:12ZzhoEditorial Office of New MedicineYixue xinzhi zazhi1004-55112023-10-0133538138810.12173/j.issn.1004-5511.2023030446415Research Progress on the osteogenic differentiation of ADSCs induced by epimedium in the prevention and treatment of osteoporosisHai-Quan LIUMei-Jian-Zong WUZu-Yu MENGOsteoporosis (OP) is a chronic, systemic bone disease. With the arrival of the aging society, the research on the prevention and treatment of this disease is increasing. Finding effective drugs to induce osteogenesis and differentiation of adipose-derived mesenchymal stem cells (ADSCs) is currently a more focused strategy for prevention and treatment of OP. Peroxisome proliferator-activated receptor gamma (PPARγ) is the key protein of adipocyte differentiation. Studies have confirmed that the intervention of epimedium on bone marrow mesenchymal stem cells (BMSCs) can inhibit the expression of PPARγ, thus inhibits adipogenic differentiation of BMSCs and promotes their osteogenic differentiation. Hippo signal pathway controls the activity of YAP/TAZ transcriptional coactivator through kinase cascade and inhibiting PPARγ, which can inhibit ADSCs from differentiating into adipocytes. Ajuba is an important regulator of adipogenic differentiation of cells and a new PPARγ interacting proteins which can limit the activity of Hippo signaling pathway during cell proliferation. Epimedium has unique advantages in the prevention and treatment of OP. Previous studies found that epimedium can promote the osteogenic differentiation of ADSCs and inhibit their lipogenic differentiation. PPARγ, Hippo pathway and Ajuba are closely related in the pathogenesis of OP. According to previous research, this paper is purposed to review the mechanism of epimedium in ADSCs for the prevention and treatment of OP, and to provide a reference for the development of new clinical drugs.https://yxxz.whuznhmedj.com/futureApi/storage/attach/2310/XLe2PMc38ZMiLCy3rWw9RFGGg1RSJ2ngw1LbtmAR.pdfepimediumosteoporosisadscsosteogenic differentiationpparγ/hippo/ajuba pathway |
| spellingShingle | Hai-Quan LIU Mei-Jian-Zong WU Zu-Yu MENG Research Progress on the osteogenic differentiation of ADSCs induced by epimedium in the prevention and treatment of osteoporosis Yixue xinzhi zazhi epimedium osteoporosis adscs osteogenic differentiation pparγ/hippo/ajuba pathway |
| title | Research Progress on the osteogenic differentiation of ADSCs induced by epimedium in the prevention and treatment of osteoporosis |
| title_full | Research Progress on the osteogenic differentiation of ADSCs induced by epimedium in the prevention and treatment of osteoporosis |
| title_fullStr | Research Progress on the osteogenic differentiation of ADSCs induced by epimedium in the prevention and treatment of osteoporosis |
| title_full_unstemmed | Research Progress on the osteogenic differentiation of ADSCs induced by epimedium in the prevention and treatment of osteoporosis |
| title_short | Research Progress on the osteogenic differentiation of ADSCs induced by epimedium in the prevention and treatment of osteoporosis |
| title_sort | research progress on the osteogenic differentiation of adscs induced by epimedium in the prevention and treatment of osteoporosis |
| topic | epimedium osteoporosis adscs osteogenic differentiation pparγ/hippo/ajuba pathway |
| url | https://yxxz.whuznhmedj.com/futureApi/storage/attach/2310/XLe2PMc38ZMiLCy3rWw9RFGGg1RSJ2ngw1LbtmAR.pdf |
| work_keys_str_mv | AT haiquanliu researchprogressontheosteogenicdifferentiationofadscsinducedbyepimediuminthepreventionandtreatmentofosteoporosis AT meijianzongwu researchprogressontheosteogenicdifferentiationofadscsinducedbyepimediuminthepreventionandtreatmentofosteoporosis AT zuyumeng researchprogressontheosteogenicdifferentiationofadscsinducedbyepimediuminthepreventionandtreatmentofosteoporosis |